Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).

Emmanuel S.  Antonarakis

Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi

Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)

Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen

Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi

Jose Maria M.  Piulats Rodriguez

Consulting or Advisory Role - Astellas Pharma; BeiGene; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences

Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche

Marine  Gross-Goupil

Consulting or Advisory Role - Amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi

Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)

Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; ipsen; MSD Oncology; Roche; Roche; Roche

Jeffrey C.  Goh

Stock and Other Ownership Interests  - Immutep

Consulting or Advisory Role - AstraZeneca; Tesaro

Speakers' Bureau - Ipsen; Janssen; Mundipharma; Novartis

Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca

Ulka N.  Vaishampayan

Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer; Sanofi

Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono; Exelixis; Pfizer

Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Pfizer; Sanofi

Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Pfizer

Ronald  De Wit

Honoraria - Merck Sharp & Dohme; Sanofi

Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen; Merck Sharp & Dohme; Roche/Genentech; Sanofi

Research Funding - Bayer (Inst); Sanofi (Inst)

Travel, Accommodations, Expenses - Bayer; Lilly

Tuomo  Alanko

Consulting or Advisory Role - Amgen; Baxalta/Shire; Bayer; Bristol-Myers Squibb; Celgene; Kaiku Health; Lilly; MSD; Nordic Drugs; Roche

Research Funding - AbbVie (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Incyte (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)

Travel, Accommodations, Expenses - Baxalta/Shire; Bristol-Myers Squibb; MSD; Pfizer; Roche

Satoshi  Fukasawa

Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Daiichi Sankyo; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda

Consulting or Advisory Role - AstraZeneca

Kenichi  Tabata

No Relationships to Disclose

Susan  Feyerabend

No Relationships to Disclose

Raanan  Berger

Stock and Other Ownership Interests  - Belong; Mitra Biotech

Honoraria - AstraZeneca; Bristol-Myers Squibb; Mitra Biotech; MSD; Pfizer; Roche Israel

Consulting or Advisory Role - Belong; Bristol-Myers Squibb; Mitra Biotech; MSD Oncology

Speakers' Bureau - Bristol-Myers Squibb; Mitra Biotech; MSD Oncology

Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Mitra Biotech; MSD

Haiyan  Wu

Employment - MSD

Stock and Other Ownership Interests  - Merck Sharp & Dohme (I)

Travel, Accommodations, Expenses - MSD RD China

Jeri  Kim

Employment - Merck

Stock and Other Ownership Interests  - Merck

Charles  Schloss

Employment - Merck; Merck

Ping  Qiu

Employment - Merck

Stock and Other Ownership Interests  - Merck

Travel, Accommodations, Expenses - Merck

Leah  Suttner

Employment - Merck

Research Funding - GlaxoSmithKline

Razvan  Cristescu

No Relationships to Disclose

Matthew John  Marton

Employment - Merck

Stock and Other Ownership Interests  - ABION; BodiGuide; Emergent BioSolutions; Exelixis; Google; Intuitive Surgical; Ions Pharmaceuticals; Merck; United Health Group

Patents, Royalties, Other Intellectual Property - Patents issued and pending (Inst)

Johann S.  De Bono

Honoraria - Astellas Pharma; AstraZeneca; BioExcel; Daiichi Sankyo; Genentech/Roche; Janssen Oncology; Menarini Silicon Biosystems; Pfizer; Sanofi; Sierra Oncology

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BioXCel therapeutics; Boehringer Ingelheim; Celgene; Daiichi Sankyo; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; Janssen Oncology; Menarini Silicon Biosystems; Merck Serono; Merck Sharp & Dohme; Orion; Pfizer; Sanofi; Sierra Oncology; Taiho Pharmaceutical

Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); CellCentric (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Medivation (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Orion (Inst); Sanofi (Inst); Sierra Oncology (Inst); Taiho Pharmaceutical (Inst)

Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); CHK1 inhibitor (Inst); PARP inhibitors and DNA repair defects (Inst); Targeting of IL23 in prostate cancer (Inst)

Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex